Features Screener Stocks Charts
Sign In Sign Up

Dr. Reddy's Laboratories Ltd. Income Statement

NSE:DRREDDY | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year DRREDDY income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 289.05B 337.41B
Cost of Revenue -82.09B -99.80B
Gross Profit 206.97B 237.61B
Sales, General & Admin -118.69B -141.17B
Operating Income 73.57B 79.41B
Profit Before Tax 71.86B 76.58B
Net Income 55.78B 57.25B
Diluted Shares 833.54M 834.18M
Diluted EPS 66.92 67.79

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025